ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.
- Revenue
- +5.93%
- EPS
- +23.1%
- Free cash flow
- −9.79%
- Total debt
- −38.9%
Quarter to September 2026, against a year earlier
Follow RMD
Alert me
ResMed Inc. (RMD) Price to free cash flow
As of 5 November 2026, ResMed Inc. (RMD) trades at a price to free cash flow of 21.5×. Over the past ten years it has ranged from 12.9× (January 2016) to 182× (August 2022); the current reading is higher than 25% of that period. That is below the Medical Instruments & Supplies industry median of 23.5× and in line with the Healthcare sector median of 21.1×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2026 | 17.4× | (24.05%) |
| FY2025 | 22.9× | 7.31% |
| FY2024 | 21.4× | (62.74%) |
| FY2023 | 57.3× | (63.47%) |
| FY2022 | 157× | 171.57% |
| FY2021 | 57.8× | 45.20% |
| FY2020 | 39.8× | (14.23%) |
| FY2019 | 46.4× | 35.78% |
| FY2018 | 34.2× | 6.35% |
| FY2017 | 32.1× | 73.97% |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Sep 2026 | 19.9× | 14.31% |
| Jun 2026 | 17.4× | (7.33%) |
| Mar 2026 | 18.8× | (4.97%) |
| Dec 2025 | 19.8× | (13.20%) |
| 43 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| SOLV Solventum Corporation compare | n/m |
| MDLN Medline Inc. compare | 11.3× |
| BAX Baxter International Inc. compare | 11.6× |
| ALGN Align Technology, Inc. compare | 16.8× |
| COO The Cooper Companies, Inc. compare | 18.1× |
| BDX Becton, Dickinson and Company compare | 18.3× |
| RMD ResMed Inc. | 21.5× |
| ALC Alcon compare | 23.3× |
| WST West Pharmaceutical Services, Inc. compare | 61.5× |
| Medical Instruments & Supplies industry median | 23.5× |
| Healthcare sector median | 21.1× |
| Market median | 14.1× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement